Fentanyl Citrate 63323-0808
Product NDC
63323-0808- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 30, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA212086
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fentanyl Citrate | 50 ug/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
10 SYRINGE in 1 CARTON (63323-808-11) / 1 mL in 1 SYRINGE (63323-808-01)